Skip to main content

Table 1 Baseline characteristics, vascular risk factors, stroke etiology, stroke severity, in-hospital complications and 90-day outcomes in humans

From: Biochemical and inflammatory biomarkers in ischemic stroke: translational study between humans and two experimental rat models

  Stroke Controls P
  (n = 51) (n = 17)  
Baseline, demographic data and risk factors    
Men, n (%) 24 (47) 8 (47) 1
Age, mean (SD) 73.5 (10.3) 70.4 (15) 0.353
Symptoms onset to first blood sample, h; mean (SD) 4.8 (3.3) 5 (3.3) 0.795
Symptoms Onset to second blood sample, h; mean (SD) 71.2 (4.9) 73.5 (4.1) 0.394
Systolic blood pressure on admission, mean (SD) 154.3 (19) 149.2 (32.3) 0.467
Blood glucose, mmol/L; median (IQR) 123 (38) 133 (106) 0.100
Hypertension, n (%) 34 (66.7) 12 (70.6) 0.765
Diabetes Mellitus, n (%) 10 (19.6) 6 (35.3) 0.187
Hyperlipidemia, n (%) 17 (33.3) 7 (41.2) 0.558
Atrial Fibrillation, n (%) 22 (43.1) 0 (0) 0.001
Current smoking, n (%) 13 (25.5) 5 (29.4) 0.751
Alcohol abuse, n (%) 2 (3.9) 2 (11.8) 1
Coronary heart disease, n (%) 8 (15.7) 2 (11.8) 1
Peripheral arterial disease, n (%) 1 (2) 2 (5.9) 0.440
Disease severity    
NIHSS score on admission, mean (SD) 11.3 (6) - -
APACHE II score on admission, mean (SD) 7.4 (2.6) 7 (2.5) 0.555
90-days outcome    
mRS 0-2, n (%) 27 (53) 10 (58.8) 0.723
Barthel index ≥ 90, n (%) 22 (43.1) 6 (35.3) 0.569
Mortality, n (%) 7 (13.7) 0 (0) 0.175
Brain infarction size, ml; median (IQR) 27.8 (78) -  
First and second tertile, ml, range 3 - 40 -  
Third tertile, ml, range 50 - 405 -  
  1. NIHSS indicates National Institutes of Health Stroke Scale; IQR, interquartile range; mRS, modified Rankin Scale.